My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

9.550 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventyx Biosciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Ventyx Crashes 81% After Scrapping Two Studies On A Psoriasis Treatment Flop ↗

November 07, 2023

The company is now scrapping studies of its drug in psoriasis and psoriatic arthritis.

Via Investor's Business Daily

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

8 Health Care Stocks Whale Activity In Today's Session ↗

November 07, 2023

Via Benzinga

Why Shares of Ventyx Biosciences Are Dropping Tuesday ↗

October 10, 2023

Investors were unimpressed by the company's trial results for an ulcerative colitis therapy.

Via The Motley Fool

Where Ventyx Biosciences Stands With Analysts ↗

August 29, 2023

Via Benzinga

Where Ventyx Biosciences Stands With Analysts ↗

August 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 07, 2023

Via Benzinga

Nasdaq Jumps 100 Points; US Trade Deficit Widens In September ↗

November 07, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The...

Via Benzinga

Topics Stocks

US Stocks Mixed; D.R. Horton Earnings Top Views ↗

November 07, 2023

U.S. stocks traded mixed this morning, with the Dow Jones falling around 50 points on Tuesday Following the market opening Tuesday, the Dow traded down 0.18% to 34,035.79 while the NASDAQ rose 0.14% to...

Via Benzinga

Topics Stocks

PTON Stock Slumps as Deutsche Bank Downgrades Peloton ↗

November 07, 2023

Peloton stock is taking a beating on Tuesday after shares of PTON were downgraded and saw their price target reduced by Deutsche Bank.

Via InvestorPlace

Why Is Psoriasis Player Ventyx Biosciences Stock Trading Lower Today? ↗

November 07, 2023

Ventyx Biosciences Inc (NASDAQ: VTYX) released results from the Phase 2 trial of VTX958 in patients with moderate to

Via Benzinga

Analyst Ratings for Ventyx Biosciences ↗

July 05, 2023

Via Benzinga

Why Is Alto Ingredients (ALTO) Stock Down 45% Today? ↗

November 07, 2023

Alto Ingredients stock is falling on Tuesday after the company released a mixed earnings report for the third quarter of the year.

Via InvestorPlace

Why Is Ventyx Biosciences (VTYX) Stock Down 76% Today? ↗

November 07, 2023

Ventyx Biosciences stock is taking a beating on Tuesday after the company announced it will end development of VTX958 on Phase 2 results.

Via InvestorPlace

Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

November 07, 2023

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 07, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 07, 2023

It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.

Via InvestorPlace

Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 07, 2023

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Crude Oil Moves Lower; Neogen Posts Downbeat Results ↗

October 10, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 175 points on Tuesday. The Dow traded up 0.53% to 33,781.59 while the NASDAQ rose 0.72% to 13,581.64. The S&P 500...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 10, 2023

Tuesday saw 132 companies set new 52-week lows.

Via Benzinga

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 10, 2023

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.

Via Benzinga

S&P 500 Rises 1%; US Wholesale Inventories Fall In August ↗

October 10, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Tuesday. The Dow traded up 0.81% to 33,876.62 while the NASDAQ rose 1.23% to 13,650.54. The S&P 500 also...

Via Benzinga

Topics Stocks

PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday ↗

October 10, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 09, 2023

Via Benzinga

Why Ventyx Biosciences Stock Fell After-Hours ↗

October 09, 2023

Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares plunged in Monday's after-hours session after the company announced results from the Phase 2 trial of VTX002 in patients with moderate-to-severely

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Analyst Boosts Protagonist Therapeutics Price Target, Says Psoriasis Data Impressive ↗

July 06, 2023

JMP Securities has increased the price target for Protagonist Therapeutics Inc (NASDAQ: PTGX) from $28 to $35,

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition